Notes - Significant Accounting Policies For Preparation Of Semi-Annual Consolidated Financial Statements

BrightPath Biotherapeutics Co., Ltd. - Filing #7580409

Concept As at
2018-03-31
2017-04-01 to
2018-03-31
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Disclosure of scope of consolidation
Number of consolidated subsidiaries and names of major consolidated subsidiaries
(1) 連結子会社の数

1社

連結子会社の名称

株式会社アドバンスト・イミュノセラピー

 

Number of consolidated subsidiaries
1 xbrli:pure
Disclosure about fiscal years, etc. of consolidated subsidiaries

2.連結子会社の事業年度等に関する事項

連結子会社の株式会社アドバンスト・イミュノセラピーの決算日は12月31日ですが、連結決算日での仮決算を行った財務諸表を使用して、連結決算を行っております。

 

Talk to a Data Expert

Have a question? We'll get back to you promptly.